Psychemedics
PMD
#8097
Rank
$14.51 M
Marketcap
$2.50
Share price
-1.19%
Change (1 day)
-48.98%
Change (1 year)

P/E ratio for Psychemedics (PMD)

P/E ratio as of May 2024 (TTM): -7.36

According to Psychemedics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.35844. At the end of 2022 the company had a P/E ratio of -25.6.

P/E ratio history for Psychemedics from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-25.6-52.51%
2021-54.0640.39%
2020-7.29-122.29%
201932.771.71%
201819.13.59%
201718.4-8.49%
201620.1-44.5%
201536.243.42%
201425.323.76%
201320.48.18%
201218.938.86%
201113.6-15.53%
201016.1-36.56%
200925.3123.63%
200811.3-39.27%
200718.7-7.9%
200620.314.53%
200517.7-24.86%
200423.5-39.69%
200339.0163.63%
200214.8-92.78%
2001205

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
20.6-379.34%๐Ÿ‡บ๐Ÿ‡ธ USA
25.7-449.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-261 3,452.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-15.3 108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.31-82.22%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.